vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.

VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). VINCE HOLDING CORP. runs the higher net margin — 3.2% vs -70.9%, a 74.1% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.2%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-5.7M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.3%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.

CTKB vs VNCE — Head-to-Head

Bigger by revenue
VNCE
VNCE
1.4× larger
VNCE
$85.1M
$62.1M
CTKB
Growing faster (revenue YoY)
CTKB
CTKB
+1.9% gap
CTKB
8.1%
6.2%
VNCE
Higher net margin
VNCE
VNCE
74.1% more per $
VNCE
3.2%
-70.9%
CTKB
More free cash flow
CTKB
CTKB
$3.9M more FCF
CTKB
$-1.8M
$-5.7M
VNCE
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
6.3%
VNCE

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CTKB
CTKB
VNCE
VNCE
Revenue
$62.1M
$85.1M
Net Profit
$-44.1M
$2.7M
Gross Margin
52.9%
49.2%
Operating Margin
-9.0%
6.4%
Net Margin
-70.9%
3.2%
Revenue YoY
8.1%
6.2%
Net Profit YoY
-557.1%
-37.3%
EPS (diluted)
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
VNCE
VNCE
Q4 25
$62.1M
$85.1M
Q3 25
$52.3M
$73.2M
Q2 25
$45.6M
$57.9M
Q1 25
$41.5M
$80.0M
Q4 24
$57.5M
$80.2M
Q3 24
$51.5M
$74.2M
Q2 24
$46.6M
$59.2M
Q1 24
$44.9M
$75.3M
Net Profit
CTKB
CTKB
VNCE
VNCE
Q4 25
$-44.1M
$2.7M
Q3 25
$-5.5M
$12.1M
Q2 25
$-5.6M
$-4.8M
Q1 25
$-11.4M
$-28.3M
Q4 24
$9.6M
$4.3M
Q3 24
$941.0K
$569.0K
Q2 24
$-10.4M
$4.4M
Q1 24
$-6.2M
$-4.7M
Gross Margin
CTKB
CTKB
VNCE
VNCE
Q4 25
52.9%
49.2%
Q3 25
52.7%
50.4%
Q2 25
52.3%
50.3%
Q1 25
48.6%
50.1%
Q4 24
58.5%
50.0%
Q3 24
56.3%
47.4%
Q2 24
54.6%
50.6%
Q1 24
51.3%
45.4%
Operating Margin
CTKB
CTKB
VNCE
VNCE
Q4 25
-9.0%
6.4%
Q3 25
-17.6%
15.2%
Q2 25
-23.3%
-7.7%
Q1 25
-36.1%
-37.1%
Q4 24
5.2%
7.2%
Q3 24
-8.2%
1.5%
Q2 24
-18.3%
9.5%
Q1 24
-23.9%
-2.2%
Net Margin
CTKB
CTKB
VNCE
VNCE
Q4 25
-70.9%
3.2%
Q3 25
-10.5%
16.5%
Q2 25
-12.2%
-8.3%
Q1 25
-27.5%
-35.5%
Q4 24
16.8%
5.4%
Q3 24
1.8%
0.8%
Q2 24
-22.4%
7.4%
Q1 24
-13.8%
-6.2%
EPS (diluted)
CTKB
CTKB
VNCE
VNCE
Q4 25
$0.21
Q3 25
$0.93
Q2 25
$-0.37
Q1 25
$-2.25
Q4 24
$0.34
Q3 24
$0.05
Q2 24
$0.35
Q1 24
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
VNCE
VNCE
Cash + ST InvestmentsLiquidity on hand
$90.9M
$1.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$53.4M
Total Assets
$461.5M
$246.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
VNCE
VNCE
Q4 25
$90.9M
$1.1M
Q3 25
$93.3M
$777.0K
Q2 25
$75.5M
$2.6M
Q1 25
$95.3M
$607.0K
Q4 24
$98.7M
$892.0K
Q3 24
$162.3M
$711.0K
Q2 24
$177.9M
$739.0K
Q1 24
$168.8M
$357.0K
Stockholders' Equity
CTKB
CTKB
VNCE
VNCE
Q4 25
$341.7M
$53.4M
Q3 25
$378.6M
$49.3M
Q2 25
$377.6M
$37.2M
Q1 25
$379.6M
$41.8M
Q4 24
$395.7M
$57.1M
Q3 24
$385.5M
$52.4M
Q2 24
$389.1M
$51.7M
Q1 24
$392.6M
$47.2M
Total Assets
CTKB
CTKB
VNCE
VNCE
Q4 25
$461.5M
$246.0M
Q3 25
$494.9M
$239.0M
Q2 25
$493.3M
$218.0M
Q1 25
$482.6M
$222.7M
Q4 24
$499.5M
$254.7M
Q3 24
$491.2M
$253.6M
Q2 24
$483.7M
$223.1M
Q1 24
$492.1M
$225.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
VNCE
VNCE
Operating Cash FlowLast quarter
$-771.0K
$-5.1M
Free Cash FlowOCF − Capex
$-1.8M
$-5.7M
FCF MarginFCF / Revenue
-2.9%
-6.7%
Capex IntensityCapex / Revenue
1.6%
0.7%
Cash ConversionOCF / Net Profit
-1.86×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
VNCE
VNCE
Q4 25
$-771.0K
$-5.1M
Q3 25
$-3.9M
$4.2M
Q2 25
$108.0K
$-11.8M
Q1 25
$-125.0K
$22.7M
Q4 24
$2.0M
$6.4M
Q3 24
$13.2M
$-3.2M
Q2 24
$6.2M
$-3.9M
Q1 24
$4.0M
$14.8M
Free Cash Flow
CTKB
CTKB
VNCE
VNCE
Q4 25
$-1.8M
$-5.7M
Q3 25
$-4.6M
$2.1M
Q2 25
$-1.5M
$-13.2M
Q1 25
$-974.0K
$21.2M
Q4 24
$1.1M
$5.1M
Q3 24
$12.2M
$-3.9M
Q2 24
$5.2M
$-4.6M
Q1 24
$3.4M
$14.2M
FCF Margin
CTKB
CTKB
VNCE
VNCE
Q4 25
-2.9%
-6.7%
Q3 25
-8.7%
2.9%
Q2 25
-3.2%
-22.9%
Q1 25
-2.3%
26.5%
Q4 24
1.9%
6.4%
Q3 24
23.7%
-5.2%
Q2 24
11.0%
-7.8%
Q1 24
7.6%
18.9%
Capex Intensity
CTKB
CTKB
VNCE
VNCE
Q4 25
1.6%
0.7%
Q3 25
1.3%
2.9%
Q2 25
3.5%
2.5%
Q1 25
2.0%
1.9%
Q4 24
1.6%
1.6%
Q3 24
2.0%
0.9%
Q2 24
2.3%
1.3%
Q1 24
1.3%
0.7%
Cash Conversion
CTKB
CTKB
VNCE
VNCE
Q4 25
-1.86×
Q3 25
0.35×
Q2 25
Q1 25
Q4 24
0.21×
1.48×
Q3 24
14.05×
-5.61×
Q2 24
-0.89×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

VNCE
VNCE

Vince Wholesale$52.0M61%
Vince Direct To Consumer$33.1M39%

Related Comparisons